Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related ALR
Canaccord Reiterates On Alere, Boosts Price Target To $60
Goldman Sachs Cuts Myriad Genetics To Sell, Ups Alere
Related SCHW
Oppenheimer Offers Deep Technical Dive Into Financials, Says Goldman, JP Morgan, Morgan Stanley 'Top Buy Ideas'
Fast Money Picks For May 12

Analysts at Wedbush downgraded Alere (NYSE: ALR) from “outperform” to “neutral.” The target price for Alere is set to $21.50. Alere's shares closed at $22.66 on Friday.

Analysts at Citigroup downgraded Charles Schwab (NYSE: SCHW) from “neutral” to “sell.” The target price for Charles Schwab has been lowered from $15 to $14. Charles Schwab's shares closed at $16.89 on Friday.

Analysts at Benchmark downgraded Fossil (NASDAQ: FOSL) from “buy” to “hold.” The target price for Fossil is set to $105. Fossil's shares closed at $103.90 on Friday.

UBS downgraded Sigma-Aldrich (NASDAQ: SIAL) from “neutral” to “sell.” The target price for Sigma-Aldrich has been lowered from $76 to $70. Sigma-Aldrich's shares closed at $77.66 on Friday.

Latest Ratings for ALR

DateFirmActionFromTo
Apr 2015Canaccord GenuityMaintainsBuy
Mar 2015Goldman SachsUpgradesSellNeutral
Mar 2015JefferiesMaintainsBuy

View More Analyst Ratings for ALR
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (FOSL + ALR)

Around the Web, We're Loving...